Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2015 Apr;33(2):480-9.
doi: 10.1007/s10637-014-0189-z. Epub 2014 Nov 29.

A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer

Joshi J Alumkal  1 , Rachel Slottke, Jacob Schwartzman, Ganesh Cherala, Myrna Munar, Julie N Graff, Tomasz M Beer, Christopher W Ryan, Dennis R Koop, Angela Gibbs, Lina Gao, Jason F Flamiatos, Erin Tucker, Richard Kleinschmidt, Motomi Mori
Affiliations
Clinical Trial

A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer

Joshi J Alumkal et al. Invest New Drugs. 2015 Apr.

Abstract

Introduction: Diets high in cruciferous vegetables are associated with lower risk of incidence of prostate cancer, including aggressive forms of this disease. Human intervention studies with cruciferous vegetable-rich diets also demonstrate modulation of gene expression in important pathways in prostate cells.

Purpose: Sulforaphane is a constituent of these foods postulated to harbor the anti-neoplastic activity based on multiple tumor models. Our own work demonstrates that sulforaphane inhibits AR signaling in prostate cancer cells. Here, we report results from the first clinical trial of sulforaphane-rich extracts in men with prostate cancer.

Methods: We treated 20 patients who had recurrent prostate cancer with 200 μmoles/day of sulforaphane-rich extracts for a maximum period of 20 weeks and determined the proportion of patients with ≥50% PSA declines, the primary endpoint. Only one subject experienced a ≥50% PSA decline. Thus, the primary endpoint was not achieved. Seven patients experienced smaller PSA declines (<50%). There was also a significant lengthening of the on-treatment PSA doubling time (PSADT) compared with the pre-treatment PSADT [6.1 months pre-treatment vs. 9.6 months on-treatment (p = 0.044)]. Finally, treatment with sulforaphane-rich extracts was safe with no Grade 3 adverse events.

Conclusions: Treatment with 200 μmoles/day of sulforaphane-rich extracts did not lead to ≥50% PSA declines in the majority of patients. However, because of the safety of treatment and the effects on PSADT modulation, further studies, including those with higher doses, may be warranted to clarify the role of sulforaphane as a prevention agent or treatment agent.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None to disclose

Figures

Fig 1
Fig 1
Waterfall plot depicting maximal PSA decline on study compared to baseline
Fig 2
Fig 2. Sulforaphane treatment and histone acetylation changes in mononuclear cells
Proteins were extracted from mononuclear cells drawn at the indicated time points before (PRE) or after sulforaphane treatment on Day 1. Western blots were used to measure levels of acetylated histone H3 (AcH3) and Actin. Blots from three patients are shown
See this image and copyright information in PMC

References

    1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA: a cancer journal for clinicians. 2014;64 (1):9–29. doi: 10.3322/caac.21208. - DOI - PubMed
    1. Cohen JH, Kristal AR, Stanford JL. Fruit and vegetable intakes and prostate cancer risk. J Natl Cancer Inst. 2000;92 (1):61–68. - PubMed
    1. Kristal AR, Lampe JW. Brassica vegetables and prostate cancer risk: a review of the epidemiological evidence. Nutrition and cancer. 2002;42 (1):1–9. doi: 10.1207/S15327914NC421_1. - DOI - PubMed
    1. Kirsh VA, Peters U, Mayne ST, Subar AF, Chatterjee N, Johnson CC, Hayes RB. Prospective study of fruit and vegetable intake and risk of prostate cancer. J Natl Cancer Inst. 2007;99 (15):1200–1209. doi: 10.1093/jnci/djm065. - DOI - PubMed
    1. Traka M, Gasper AV, Melchini A, Bacon JR, Needs PW, Frost V, Chantry A, Jones AM, Ortori CA, Barrett DA, Ball RY, Mills RD, Mithen RF. Broccoli consumption interacts with GSTM1 to perturb oncogenic signalling pathways in the prostate. PLoS One. 2008;3 (7):e2568. doi: 10.1371/journal.pone.0002568. - DOI - PMC - PubMed

Publication types